5-MeO-DMT
We are developing a clinical trial study on 5-methoxy-N,N-dimethyltryptamine (5-MeO-N,N-DMT). This will be an infusion study similar to previous studies on N, N-DMT only using 5-MeO-N, N-DMT instead. The first study will be an FDA and DEA approved phase 1 clinical trial of this substance being used in humans and will focus primarily on safety and documentation of any adverse events.
LSD Microdosing
We are developing studies examining the effects of microdosing Lysergic acid diethylamide (LSD). Including a prospective observational study along with a clinical trials set of studies with the microdosing of psychedelics.
For more information on our current projects please contact our Principal Investigator: richard.knowles@delospsyche.org